Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent advances in antiretroviral therapy of HIV infection.
Vella S, Fragola V, Palmisano L. Vella S, et al. Among authors: palmisano l. J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):60-3. J Biol Regul Homeost Agents. 1997. PMID: 9418165 Review. No abstract available.
HIV therapy in the post-eradication era.
Vella S, Palmisano L. Vella S, et al. Among authors: palmisano l. J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):34-7. J Biol Regul Homeost Agents. 2000. PMID: 10763890
Antiretroviral therapy: state of the HAART.
Vella S, Palmisano L. Vella S, et al. Among authors: palmisano l. Antiviral Res. 2000 Jan;45(1):1-7. doi: 10.1016/s0166-3542(99)00068-6. Antiviral Res. 2000. PMID: 10774585 Review. No abstract available.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A; NEAT001/ANRS143 Study Group. Raffi F, et al. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4. Lancet. 2014. PMID: 25103176 Clinical Trial.
HIV eradication revisited.
Vella S, Palmisano L. Vella S, et al. Among authors: palmisano l. Expert Opin Investig Drugs. 2000 Feb;9(2):193-7. doi: 10.1517/13543784.9.2.193. Expert Opin Investig Drugs. 2000. PMID: 11060670
HIV-1 coreceptor switch during 2 years of structured treatment interruptions.
Baroncelli S, Galluzzo CM, Andreotti M, Pirillo MF, Fragola V, Weimer LE, Giuliano M, Vella S, Palmisano L. Baroncelli S, et al. Among authors: palmisano l. Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1565-70. doi: 10.1007/s10096-013-1911-z. Epub 2013 Jul 4. Eur J Clin Microbiol Infect Dis. 2013. PMID: 24213914 Clinical Trial.
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F; NEAT 001/ANRS 143 Study Group. Lambert-Niclot S, et al. Among authors: palmisano l. J Antimicrob Chemother. 2016 Apr;71(4):1056-62. doi: 10.1093/jac/dkv427. Epub 2015 Dec 24. J Antimicrob Chemother. 2016. PMID: 26702926 Free article. Clinical Trial.
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
d'Ettorre G, Forcina G, Andreotti M, Sarmati L, Palmisano L, Andreoni M, Vella S, Mastroianni CM, Vullo V. d'Ettorre G, et al. Among authors: palmisano l. Clin Exp Immunol. 2004 Feb;135(2):280-5. doi: 10.1111/j.1365-2249.2004.02373.x. Clin Exp Immunol. 2004. PMID: 14738457 Free PMC article.
Updated European recommendations for the clinical use of HIV drug resistance testing.
Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, Banhegyi D, Boucher C, Brun-Vézinet F, Camacho R, Clevenbergh P, Clumeck N, Dedes N, De Luca A, Doerr HW, Faudon JL, Gatti G, Gerstoft J, Hall WW, Hatzakis A, Hellmann N, Horban A, Lundgren JD, Kempf D, Miller M, Miller V, Myers TW, Nielsen C, Opravil M, Palmisano L, Perno CF, Phillips A, Pillay D, Pumarola T, Ruiz L, Salminen M, Schapiro J, Schmidt B, Schmit JC, Schuurman R, Shulse E, Soriano V, Staszewski S, Vella S, Youle M, Ziermann R, Perrin L. Vandamme AM, et al. Among authors: palmisano l. Antivir Ther. 2004 Dec;9(6):829-48. Antivir Ther. 2004. PMID: 15651743
179 results